Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph early_phase_1
1
33%
Ph not_applicable
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

completed267%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedearly_phase_1

AIH for Spinal Cord Repair

NCT03780829
completednot_applicable

Intermittent Hypoxia Paired with High Intensity Training in Brain Injury

NCT04472442
completednot_applicable

Acute Intermittent Hypoxia in Persons With Multiple Sclerosis

NCT04280484

Clinical Trials (3)

Showing 3 of 3 trials
NCT03780829Early Phase 1

AIH for Spinal Cord Repair

Terminated
NCT04472442Not Applicable

Intermittent Hypoxia Paired with High Intensity Training in Brain Injury

Completed
NCT04280484Not Applicable

Acute Intermittent Hypoxia in Persons With Multiple Sclerosis

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3